Patient P-02582
Synthetic patientMETA-24 · Day 177 · 55–64 · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Unstable
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
96%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S14
- Day 75 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 80 ME-01 recommended — Monitoring Escalation ME-01
- Day 81 Patient accepted — Started ME-01 in the companion
- Day 84 Deterioration detected before clinical escalation — Monitoring Escalation ME-01
What changed?
Trajectory began diverging from predicted response on Day 75.
Primary contributors, last 14 days
- Toxicity+9
- Inflammatory activity+8
- GI instability-4
- Nutritional resilience+3
What helped?
- Monitoring Escalation ME-01Day 80Result: deterioration detected before clinical escalation
LIFE OS recommendation
GI Support Protocol GI-04
92%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 88% showed improvement
- median effect visible after 8 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable9 min
worsening · -2.0 vs previous 14 d
Sleep duration
Wearable6.4 h
stable · -0.0 vs previous 14 d
Energy level
Daily log2.2/10
worsening · -0.4 vs previous 14 d
Steps
Wearable1,624
worsening · -141 vs previous 14 d
GI burden
Companion70.2/100
worsening · +7.7 vs previous 14 d
Adherence
Companion44.9 %
improving · +3.0 vs previous 14 d
Sleep quality
Wearable17.2/100
worsening · -1.3 vs previous 14 d
Glucose, CGM daily mean
CGM146 mg/dL
stable · +3.7 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 21 from the failing basin, 79 from restoration.
Would help
- GI-04 GI Support Protocol76% improved among 66 similar · onset 8 d · confidence 95%
- NP-02 Dietary Support Protocol59% improved among 32 similar · onset 10 d · confidence 69%
- SC-12 Supportive Compound69% improved among 26 similar · onset 6 d · confidence 69%
- More proteinGI -3.7 next day on high-intake days · n 16
Would not help
- Keep fat lowGI +2.6 next day on high-intake days · n 23
- Keep alcohol lowGI +2.4 next day on high-intake days · n 23
- Keep ultra-processed lowGI +2.4 next day on high-intake days · n 16
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.7supporter · 95%
- Dietary fat load+2.6detractor · 95%
- Alcohol+2.4detractor · 89%
- Ultra-processed food+2.4detractor · 85%
- Simple carbohydrates-0.6no signal · 17%
- Caffeine-0.4no signal · 15%
- Histamine load+0.3no signal · 15%
- Insoluble fibre-0.3no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↑85
- DNAIL6 -174 variant raises baseline inflammatory tone
- MicrobiomeBacteroides fragilis expansion
- BloodInflammatory load index 70
- WearableHRV 15 ms, trending down
- Butyrate / short-chain fatty acid production ↓80
- MicrobiomeButyrate capacity 22/100
- MicrobiomeF. prausnitzii depleted
- Daily logFibre intake low in recent food logs
- Autonomic recovery ↓65
- WearableResting HR 90 bpm
- Wearable1,624 steps/day
- WearableShort sleep window
- Mucosal barrier integrity ↓20
- Daily logGI symptom score 70 and rising
- Drug metabolism and exposure ↑20
- BloodToxicity index 64
DNA
Fictional pharmacogenomic panel
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Normal metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3 · butyrate capacity 22/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 18 ms
- Sleep
- 6.7 h
- Steps
- 1,779
- Resting HR
- 89 bpm
Daily log: GI score 70, nutritional resilience 30, adherence 45.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
- Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Track each bowel movement today: time, stool form, urgency, overnight waking
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- Electrolyte solution, one sachet after any loose stool
- Fictional demo item: oral nutrition supplement with lunch
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.